In the tumor microenvironment (TME), tumor-associated macrophages (TAMs) are the most
abundant immune cells, which act as a key regulator in tumorigenesis and progression …

The standard therapies in lymphoma have predominantly focused on targeting tumor cells
with less of a focus on the tumor microenvironment (TME), which plays a critical role in …

Sono‐immunotherapy holds great potential for deep tumor inhibition; however, smart sono‐
therapeutic agents to simultaneously eliminate 'domestic'tumor cells and regulate the …

Mantle cell lymphoma (MCL), a rare and aggressive B-cell non-Hodgkin lymphoma, mainly
develops in the lymph node (LN) and creates a protective and immunosuppressive niche …

Follicular lymphoma, the most common indolent lymphoma, though highly responsive to
therapy is coupled with multiple relapses for the majority of patients. Advances in biologic …

Here, we fabricated nanoparticles made solely from the membrane of cells found in the
pancreatic tumour's microenvironment (TME), like the human MiaPaCa-2 cells and M2 …

Background: Immunotherapy has completely changed the treatment of solid tumors.
Although immune checkpoint inhibitors (ICIs) seem to be an appealing alternative to …

Microglia, traditionally regarded as innate immune cells in the brain, drive
neuroinflammation and synaptic dysfunctions in the early phases of Alzheimer disease (AD) …

Mounting evidence has revealed that many nontumor cells in the tumor microenvironment,
such as fibroblasts, endothelial cells, mesenchymal stem cells, and leukocytes, are strongly …

Background Colony-stimulating factor 1 receptor (CSF1R), a classic tyrosine kinase
receptor, has been identified as a proto-oncogene in multiple cancers. The CSF1/CSF1R …